Cite
MLA Citation
Clarice S. Groeneveld et al.. “Tertiary lymphoid structures marker CXCL13 is associated with better survival for patients with advanced-stage bladder cancer treated with immunotherapy.” European journal of cancer, vol. 148, 2021, pp. 181–189. http://access.bl.uk/ark:/81055/vdc_100129509526.0x00002c